Exact Mass: 604.1692

Exact Mass Matches: 604.1692

Found 16 metabolites which its exact mass value is equals to given mass value 604.1692, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Ferrocytochrome

15,19-bis(2-carboxyethyl)-9-ethenyl-4,5,10,14,20-pentamethyl-2lambda5,22,23lambda5,25-tetraaza-1-ferraoctacyclo[11.9.1.1^{1,8}.1^{3,21}.0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-2,4,6,8,10,12,14,16(23),17,19,21(24)-undecaene-2,23-bis(ylium)

C33H32FeN4O4 (604.1773)


Ferricytochrome is a cytochrome containing reduced (ferrous) iron. Cytochrome c is an electron-carrying protein found in mitochondria of all aerobic organisms. It is part of the terminal oxidation chain, which completes the breakdown of foods to COZ and HzO, storing the liberated chemical energy in molecules of ATP. Like myoglobin, it is an iron porphyrin protein, made up of one heme group and one polypeptide chain. The iron atomalternates between the +2 and +3 oxidation state as the molecule interacts in turn with cytochrome reductase and cytochrome oxidase, each a large multimolecular complex (l-3). One of the goals of the present x-ray analysis is to understand how electron. transfer occurs into and out of cytochrome c, which will ultimately require a knowledge of the molecular structure in both the ferric and ferrous states. Ferricytochrome is a cytochrome containing reduced (ferrous) iron.

   

Penta-Ac-Aloesin

Penta-Ac-Aloesin

C29H32O14 (604.1792)


   

6?-O-p-hydroxybenzoyl-6-O-p-hydroxybenzoyl-5,7-bisdeoxycynanchoside

6?-O-p-hydroxybenzoyl-6-O-p-hydroxybenzoyl-5,7-bisdeoxycynanchoside

C29H32O14 (604.1792)


   

kaempferol 3-O-alpha-L-(4-O-acetyl)rhamnopyranoside-7-O-alpha-L-rhamnopyranoside|sutchuenoside A

kaempferol 3-O-alpha-L-(4-O-acetyl)rhamnopyranoside-7-O-alpha-L-rhamnopyranoside|sutchuenoside A

C29H32O14 (604.1792)


   

(-)-1,2-Bis[(2R,5R)-dimethylphospholano]benzene(cyclooctadiene)rhodium(I) tetrafluoroborate

(-)-1,2-Bis[(2R,5R)-dimethylphospholano]benzene(cyclooctadiene)rhodium(I) tetrafluoroborate

C26H40BF4P2Rh (604.1689)


   

(1R,2S,3S,4R,5S)-1-(acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triyltriacetate

(1R,2S,3S,4R,5S)-1-(acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triyltriacetate

C30H33ClO11 (604.1711)


   
   

HCH-acetylsalicortin

HCH-acetylsalicortin

C29H32O14 (604.1792)


   

N-[(5S,6R,9R)-8-(3-chlorophenyl)sulfonyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide

N-[(5S,6R,9R)-8-(3-chlorophenyl)sulfonyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide

C28H33ClN4O7S (604.1758)


   

IPN60090 (dihydrochloride)

IPN60090 (dihydrochloride)

C24H29Cl2F3N8O3 (604.1692)


IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1?(GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 dihydrochloride can be used for solid tumors research, such as lung and ovarian cancers[1][2].

   

[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-[(4-hydroxy-3-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]methyl acetate

[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-[(4-hydroxy-3-methyl-9,10-dioxoanthracen-2-yl)oxy]-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]methyl acetate

C29H32O14 (604.1792)


   

(2e)-3-({[(2r,3r,4s,5s,6r)-6-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)-4-hydroxybut-2-en-1-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

(2e)-3-({[(2r,3r,4s,5s,6r)-6-({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)-4-hydroxybut-2-en-1-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C29H32O14 (604.1792)


   

(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-[(5-hydroxy-4-oxo-2-phenyl-7-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-3-yl)oxy]-2-methyloxan-3-yl acetate

(2s,3r,4s,5r,6s)-4,5-dihydroxy-6-[(5-hydroxy-4-oxo-2-phenyl-7-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}chromen-3-yl)oxy]-2-methyloxan-3-yl acetate

C29H32O14 (604.1792)


   

3-({[6-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)-4-hydroxybut-2-en-1-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

3-({[6-({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)-4-hydroxybut-2-en-1-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C29H32O14 (604.1792)


   

4,5-dihydroxy-6-({5-hydroxy-4-oxo-2-phenyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]chromen-3-yl}oxy)-2-methyloxan-3-yl acetate

4,5-dihydroxy-6-({5-hydroxy-4-oxo-2-phenyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]chromen-3-yl}oxy)-2-methyloxan-3-yl acetate

C29H32O14 (604.1792)